BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tanda ET, d'Amato AL, Rossi G, Croce E, Boutros A, Cecchi F, Spagnolo F, Queirolo P. Merkel Cell Carcinoma: An Immunotherapy Fairy-Tale? Front Oncol 2021;11:739006. [PMID: 34631574 DOI: 10.3389/fonc.2021.739006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Royapuram Parthasarathy P. Merkel cell carcinoma – Time to consider personalized medicine and combinatorial therapeutic strategies. Oral Oncology 2022;135:106220. [DOI: 10.1016/j.oraloncology.2022.106220] [Reference Citation Analysis]
2 Akaike T, Cahill K, Akaike G, Huynh ET, Hippe DS, Shinohara MM, Liao J, Apisarnthanarax S, Parvathaneni U, Hall E, Bhatia S, Cheng RK, Nghiem P, Tseng YD. Management and Prognosis of Cardiac Metastatic Merkel Cell Carcinoma: A Case-Control Study and Literature Review. Cancers (Basel) 2022;14. [PMID: 36497395 DOI: 10.3390/cancers14235914] [Reference Citation Analysis]
3 Bi A, Yang S, Ding Y, Yu Y, Zhan W, Song T. Prognostic Value of Radiotherapy and Chemotherapy in Stage I–III Merkel Cell Carcinoma. Front Med 2022;9:845905. [DOI: 10.3389/fmed.2022.845905] [Reference Citation Analysis]